에 대한 최신 뉴스 Fortive (NYSE:FTV) 주식

Fortive

Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.2 billion in revenue in 2024.

Earnings

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

포티브 코퍼레이션(NYSE:FTV)은 2025년 2월 7일 금요일 개장 전에 4분기 재무 실적을 발표할 예정이다. 

곧 4분기 실적 발표하는 포티브, 최근 애널리스트 의견 변동은?

Fortive Corp

HC Wainwright &amp; Co. analyst Robert Burns maintains Zymeworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYME#NASDAQ">ZYME</a>) with a Neutral and raises the price target from $12 to $13.

ZYME

HC Wainwright & Co. Maintains Neutral on Zymeworks, Raises Price Target to $13

American consumers received a temporary reprieve Thursday when President Donald Trump signed executive actions delaying tariffs on products from Mexico and Canada covered by the United States-Mexico-Canada Agreement <a href="https://www.benzinga.com/25/03/44149833/trump-delays-ford-gm-stellantis-from-from-tariffs-on-mexico-canada-for-one-month">until April 2</a>. 
&#8220;After speaking with President Claudia Sheinbaum of Mexico, I have agreed that Mexico will not be required to pay Tariffs on anything that falls under the USMCA Agreement,&#8221; <a href="https://truthsocial.com/@realDonaldTrump/posts/114116432894994278">Trump wrote on Truth Social</a>. The president cited border security cooperation and fentanyl interdiction efforts as reasons for the delay.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now </a></li>
</ul>
The postponement affects goods that would have faced a 25% tariff, sparing numerous everyday products from immediate price increases. 
Automobiles were among the most significant items affected by the delay. <a href="https://www.cato.org/blog/seven-charts-show-how-us-tariffs-would-harm-american-auto-industry">According to the Cato Institute</a>, new cars and trucks, which rely heavily on parts manufactured in Canada and Mexico, would likely have seen immediate price increases under the tariffs.
According to <a href="https://www.newsweek.com/us-products-more-expensive-after-trump-tariffs-2039096">Newsweek</a>, popular Mexican beers like Modelo and Corona also avoid immediate price hikes, as do avocados—90% of which come from Mexico. Building materials receive temporary relief as well, with about one-third of softwood lumber used in U.S. home construction coming from Canada.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates. </a>
However, not all products are covered by the pause. A <a href="https://www.cnn.com/2025/03/06/economy/tariffs-delay-mexico-canada/index.html">White House official told CNN</a> that about 50% of imports from Mexico and 36% from Canada fall under the USMCA agreement. Energy imports from Canada, including crude oil that accounts for 61% of U.S. oil imports, remain subject to a 10% tariff, likely affecting gas prices, particularly in the Northeast. 
The sudden policy shift represents a walkback of Trump&#8217;s trade agenda that had rattled markets. The S&amp;P 500 <a href="https://www.benzinga.com/25/03/44118620/whats-driving-markets-tuesday">had plunged 1.7% on Tuesday</a>—its steepest one-day drop this year—when Trump insisted the tariffs would proceed. 
The reprieve comes with caveats. The White House has made clear the delay is temporary, with tariffs potentially taking effect on April 2 unless further agreements are reached.&nbsp;
See Also: Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed! </a>Canadian Prime Minister Justin Trudeau said all of Canada&#8217;s retaliatory measures would remain in place. Ontario Premier Doug Ford confirmed to CNN that his province still plans to implement a 25% tariff on electricity exports to 1.5 million American homes in Minnesota, Michigan and New York next week.
 While consumers have a one-month reprieve from potential price increases on many everyday items, <a href="https://www.cnn.com/2025/03/06/economy/tariffs-delay-mexico-canada/index.html">CNN noted</a> that businesses warn the uncertainty itself could create economic drag as companies hesitate to make investments amid unpredictable trade policy.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
</ul>

Personal Finance

From Cars To Avocados—What's Spared In Trump's Tariff Pause

Investors with a lot of money to spend have taken a bearish stance on AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ASTS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 71 uncommon options trades for AST SpaceMobile.
This isn't normal.
The overall sentiment of these big-money traders is split between 38% bullish and 43%, bearish.
Out of all of the special options we uncovered, 8 are puts, for a total amount of $1,023,593, and 63 are calls, for a total amount of $6,049,168.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $50.0 for AST SpaceMobile over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in AST SpaceMobile's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to AST SpaceMobile's substantial trades, within a strike price spectrum from $5.0 to $50.0 over the preceding 30 days.
<h3>AST SpaceMobile Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741626065_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$21.3</td>
<td>$20.5</td>
<td>$20.09</td>
<td>$40.00</td>
<td>$399.4K</td>
<td>121</td>
<td>20</td>
</tr>
<tr>
<td>ASTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$22.45</td>
<td>$20.75</td>
<td>$20.75</td>
<td>$40.00</td>
<td>$344.0K</td>
<td>121</td>
<td>2.0K</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$14.0</td>
<td>$13.85</td>
<td>$14.0</td>
<td>$20.00</td>
<td>$210.0K</td>
<td>838</td>
<td>159</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$16.7</td>
<td>$16.4</td>
<td>$16.53</td>
<td>$15.00</td>
<td>$132.2K</td>
<td>2.1K</td>
<td>240</td>
</tr>
<tr>
<td>ASTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$16.5</td>
<td>$16.4</td>
<td>$16.5</td>
<td>$15.00</td>
<td>$132.0K</td>
<td>2.1K</td>
<td>320</td>
</tr>
</tbody>
</table>

<h3>About AST SpaceMobile</h3>
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
In light of the recent options history for AST SpaceMobile, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of AST SpaceMobile</h3>
<ul>
<li>Trading volume stands at 8,510,441, with ASTS's price down by -9.91%, positioned at $30.09.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 65 days.</li>
</ul>
<h3>What Analysts Are Saying About AST SpaceMobile</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $38.63.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on AST SpaceMobile with a target price of $38. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $30. 
&#x2A; An analyst from Scotiabank has decided to maintain their Sector Outperform rating on AST SpaceMobile, which currently sits at a price target of $47. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AST SpaceMobile options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

ASTS

Spotlight on AST SpaceMobile: Analyzing the Surge in Options Activity

Investors with a lot of money to spend have taken a bullish stance on Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with EL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 18 uncommon options trades for Estee Lauder Cos.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 33%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $349,749, and 14 are calls, for a total amount of $684,143.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $100.0 for Estee Lauder Cos over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Estee Lauder Cos options trades today is 670.17 with a total volume of 2,525.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Estee Lauder Cos's big money trades within a strike price range of $40.0 to $100.0 over the last 30 days.
<h3>Estee Lauder Cos Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741626061_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>EL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$5.25</td>
<td>$5.2</td>
<td>$5.25</td>
<td>$50.00</td>
<td>$148.6K</td>
<td>771</td>
<td align="right">297</td>
</tr>
<tr>
<td>EL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$5.25</td>
<td>$5.2</td>
<td>$5.25</td>
<td>$50.00</td>
<td>$139.6K</td>
<td>771</td>
<td align="right">614</td>
</tr>
<tr>
<td>EL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$19.75</td>
<td>$19.6</td>
<td>$19.75</td>
<td>$54.00</td>
<td>$79.0K</td>
<td>1</td>
<td align="right">84</td>
</tr>
<tr>
<td>EL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$5.4</td>
<td>$5.2</td>
<td>$5.24</td>
<td>$70.00</td>
<td>$65.5K</td>
<td>2.1K</td>
<td align="right">146</td>
</tr>
<tr>
<td>EL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$35.25</td>
<td>$33.3</td>
<td>$34.3</td>
<td>$40.00</td>
<td>$65.1K</td>
<td>3</td>
<td align="right">44</td>
</tr>
</tbody>
</table>

<h3>About Estee Lauder Cos</h3>
Estee Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
After a thorough review of the options trading surrounding Estee Lauder Cos, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Estee Lauder Cos's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,307,930, the price of EL is up by 0.49%, reaching $73.67.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 52 days from now.</li>
</ul>
<h3>Expert Opinions on Estee Lauder Cos</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $81.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Buy rating for Estee Lauder Cos, targeting a price of $81. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Estee Lauder Cos with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Spotlight on Estee Lauder Cos: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Robinhood Markets.
Looking at options history for Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) we detected 75 trades.
If we consider the specifics of each trade, it is accurate to state that 48% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 13 are puts, for a total amount of $838,514 and 62, calls, for a total amount of $4,549,122.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $12.0 and $80.0 for Robinhood Markets, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Robinhood Markets's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Robinhood Markets's whale activity within a strike price range from $12.0 to $80.0 in the last 30 days. 
<h3>Robinhood Markets Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741626055_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.25</td>
<td>$10.1</td>
<td>$10.25</td>
<td>$40.00</td>
<td>$991.0K</td>
<td>11.1K</td>
<td>9.1K</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.3</td>
<td>$12.15</td>
<td>$12.3</td>
<td>$35.00</td>
<td>$361.6K</td>
<td>10.6K</td>
<td>360</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$4.1</td>
<td>$4.0</td>
<td>$4.1</td>
<td>$70.00</td>
<td>$205.0K</td>
<td>62</td>
<td>4.0K</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$4.25</td>
<td>$4.1</td>
<td>$4.1</td>
<td>$70.00</td>
<td>$205.0K</td>
<td>62</td>
<td>2.5K</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/14/25</td>
<td>$6.8</td>
<td>$6.65</td>
<td>$6.73</td>
<td>$44.50</td>
<td>$134.6K</td>
<td>1.3K</td>
<td>21</td>
</tr>
</tbody>
</table>

<h3>About Robinhood Markets</h3>
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.
After a thorough review of the options trading surrounding Robinhood Markets, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Robinhood Markets</h3>
<ul>
<li>Currently trading with a volume of 42,026,917, the HOOD's price is down by -15.34%, now at $37.6. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 58 days.</li>
</ul>
<h3>What The Experts Say On Robinhood Markets</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $66.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Robinhood Markets, maintaining a target price of $76. 
&#x2A; An analyst from Keybanc persists with their Overweight rating on Robinhood Markets, maintaining a target price of $75. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Neutral rating on Robinhood Markets with a target price of $45. 
&#x2A; An analyst from JMP Securities has decided to maintain their Market Outperform rating on Robinhood Markets, which currently sits at a price target of $77. 
&#x2A; An analyst from Keefe, Bruyette &amp; Woods persists with their Market Perform rating on Robinhood Markets, maintaining a target price of $60. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Robinhood Markets, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

HOOD

Robinhood Markets's Options Frenzy: What You Need to Know

CNBC Halftime Report Final Trades: Delta Air Lines, Exxon Mobil, Gap, CME Group

RBC Capital analyst Keith Mackey maintains Ensign Energy Services (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ESI#TSX">ESI</a>) with a Outperform and lowers the price target from C$4.25 to C$3.5.

TSX:ESI

RBC Capital Maintains Outperform on Ensign Energy Services, Lowers Price Target to C$3.5

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) drop below $80,000 has traders questioning whether this is a healthy correction or a <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44048486/bitcoins-24-correction-mostly-technical-say-experts">prime buying opportunity</a>.
What Happened: In a detailed X <a href="https://x.com/StockmoneyL/status/1899052074978939307">post</a> on Monday, crypto trader Stockmoney Lizards posited that traders are rushing to buy the dip, but technical analysis suggests Bitcoin's pullback may not be over yet. 
While long-term fundamentals remain strong, history and current price action indicate further downside is possible before the next leg up. The trader flagged several relevant technical indicators:
200-Day Simple Moving Average History:
<ul>
<li>Previous corrections (2023 &amp; 2024) saw Bitcoin trade below the 200-day SMA for weeks.</li>
<li>This pattern seems to be repeating in 2025.</li>
</ul>
Liquidity Support Zones:
<ul>
<li>2023 correction found support at ~$25,000, 2024 at ~$50,000.</li>
<li>Current cycle suggests support in the $72,000–$74,000 range.</li>
</ul>
Short-Term Breakdown:
<ul>
<li>Bitcoin broke below its uptrend after two retests.</li>
<li>A bearish retest signals potential further downside.</li>
<li>Many traders still hold unrealized gains from the $70,000 to $108,000 move, suggesting more selling pressure.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44218404/raoul-pal-sees-bitcoin-solana-in-healing-stage-predicts-market-recovery-in-q2">Raoul Pal Sees Bitcoin, Solana In &#8216;Healing Stage&#8217;, Predicts Market Recovery In Q2</a>
What's Next: Stockmoney Lizards predicts for the short term, more downside is expected. 
For the longer term, the trader reaffirms his $200,000 target by year-end, telling his followers to hold on to their positions, as he sees the market in a &#8220;healthy consolidation.&#8221;
Crypto trader Javon Marks <a href="https://twitter.com/JavonTM1/status/1899106809450791310">noted</a> that Bitcoin is following a similar hidden bullish divergence that in the past triggered an approximate 90% rally. 
This could potentially mark that the market could be gearing up for another strong bullish move.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44214520/successful-bitcoin-short-trader-places-take-profit-levels-between-70000-74000further-drop-incoming">Successful Bitcoin Short Trader Places Take Profit Levels Between $70,000-$74,000: Further Drop Incoming?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin's Drops Below $80,000: Correction Or Buying Opportunity?

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Palantir Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) leading tech companies lower. The S&amp;P 500 and Dow Jones were also firmly r<a href="https://www.benzinga.com/25/03/44222440/financial-crime-weekly">ed in midday trading.&nbsp;</a>
President Donald Trump seemed to acknowledge the possibility of a U.S. recession in an interview with Fox News on Sunday when he referred to the current economic situation as a "period of transition"&nbsp;further fueling economic concerns. 
Read Next: <a href="https://www.benzinga.com/news/econ-s/25/03/44143666/us-services-sector-unexpectedly-expands-in-february-despite-slowing-job-growth">US Services Sector Unexpectedly Expands In February Despite Slowing Job Growth</a>
Last week, Fed Chair Jerome Powell acknowledged the current economic uncertainty and investors look to this week's Consumer Price Index and Producer Price Index data, ahead of next week's Federal Open Market Committee meeting. February's jobs report released last week signaled a softening labor market and the ISM Manufacturing PMI showed firms are already experiencing disruptions from the Trump administration's tariff policies.
The yield on U.S. 10-year Treasury note fell to 4.23% on Monday amid economic uncertainty and the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) rose 1.33%.&nbsp;
U.S. natural gas futures rose as high as $4.60 MMBtu driven by extremely cold weather across North America and Europe, supply constraints and record LNG exports. The United States Natural Gas Fund LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNG#NYSE">UNG</a>) was up 3.21% midday.&nbsp;
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) traded below the $80,000 level, down nearly 17% for the month.&nbsp;
<h1 class="wp-block-heading">Monday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1 day % chg.</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,571.14</td>
<td>-3.34%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,649.85</td>
<td>-2.09%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,321.75</td>
<td>-1.12%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,042.10</td>
<td>-1.60%</td>
</tr>
</tbody>
</table>
</figure>
According to Benzinga Pro data:
<ul>
<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 2.22% to $563.13.</li>
<li>The SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) was down 1.24% at $422.96.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) dropped 3.33% to $475.43.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) slipped 1.56% to $202.74.</li>
<li>The Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) fell 2.62% to $200.28.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)&nbsp;rose 0.77% to $88.08.</li>
</ul>
<h1 class="wp-block-heading">Monday's Stock Movers&nbsp;</h1>
Shares of Redfin, Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>) soared after Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) announced it would acquire <a href="https://www.benzinga.com/news/25/03/44218758/rocket-wants-1-75-billion-redfin-deal-to-change-how-america-buys-homes">the company</a> in a $1.75 billion all-stock transaction. &nbsp;<a href="https://www.benzinga.com/quote/avgo" target="_blank" rel="noreferrer noopener"></a>
Stocks reacting to company earnings reports included:&nbsp;
<ul>
<li>Aligos Therapeutics, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>)</li>
<li>Fennec Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>)</li>
<li>BioNTech SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>)&nbsp;</li>
<li>Telos Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>)</li>
<li>Rand Capital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAND#NASDAQ">RAND</a>)</li>
<li>NET Power Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>)</li>
</ul>
Companies reporting on after the bell include:
<ul>
<li>Oracle Corp.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)</li>
<li>Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>)</li>
<li>Asana, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>)</li>
<li>LifeMD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>)</li>
<li>Grupo Supervielle S.A.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUPV#NYSE">SUPV</a>)</li>
<li>Hesai Group&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>)</li>
<li>Redwire Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>)</li>
</ul>
Read Next:<a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying" target="_blank" rel="noreferrer noopener">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/03/44098232/markets-tank-after-trump-confirms-more-tariffs-heres-what-wall-street-is-saying" target="_blank" rel="noreferrer noopener">Markets Tank After Trump Confirms More Tariffs: Here&#8217;s What Wall Street Is Saying</a></li>
</ul>
Photo: Shutterstock

Equities

Market Summary

Commodities

Economics

Federal Reserve

Movers

General

ALGS

ASAN

BNTX

SPDR Dow Jones Industrial Average ETF Trust

FENC

HSAI

LFMD

NPWR

ORCL

PLTR

RAND

RDFN

SUPV

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

Select Sector SPDR-Consumer Discretionary

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?

Rosenblatt analyst Kevin Cassidy reinstated coverage on Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with a Buy and a <a href="https://www.benzinga.com/quote/SMCI/analyst-ratings" target="_blank" rel="noreferrer noopener">$60 price target</a>.
Supermicro is a leading provider of customizable, high-performance, energy-efficient server and storage solutions, catering to the rapidly growing demands of AI, cloud, enterprise, and edge computing. Focusing on innovation, security, and global manufacturing expansion, the company is well-positioned to capitalize on industry trends.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/buybacks/25/03/44218819/applied-materials-hikes-dividend-for-8th-year-greenlights-10-billion-buyback-to-reward-investors" rel="noreferrer noopener">Applied Materials Hikes Dividend For 8th Year, Greenlights $10 Billion Buyback to Reward Investors</a>
By investing in cutting-edge technologies, supply chain diversification, and cost optimization, Supermicro strengthens its competitive edge in the evolving IT infrastructure landscape.
Supermicro has benefited from the emerging importance of generative AI themes as investors have started to appreciate the company&#8217;s inherent innovation, design, deployment, and manufacturing scale capabilities, the analyst says.
AI revenues are now nearly 70% of sales and are accelerating, with visibility increasing to 1-2 years.
Supermicro&#8217;s long history in &#8220;Green&#8221; computing, building block architecture (BBA), plug-and-play, Twin architecture, rack-scale integration, and S/W platform optimization has resulted in a formidable business model aligned with the critical factors for success in an AI-driven world where time-to-market, TCO optimization, scale, and reliability are of the utmost importance, according to the analyst.
Cassidy noted the company&#8217;s ability to deliver liquid cooling at scale as a competitive advantage. Given the complexity, expense, and reliability concerns (leaks or droplets), liquid cooling at scale has been quite difficult to deploy.
At scale, Supermicro&#8217;s liquid cooling technology can increase rack compute power by over 2 times, which the analyst noted as a disruptive dynamic in a power-constrained data center.
Cassidy modeled fiscal 2025 sales of $24.3 billion (+62% Y/Y), adjusted gross margins of 12.3%, and adjusted EPS of $2.63. This is versus the consensus of $24.1 billion (+61% Y/Y), 12.3%, and $2.63. 
The analyst modeled fiscal 2026 sales of $33.0 billion (+36% Y/Y), adjusted gross margins of 12.6%, and adjusted EPS of $3.82. This is versus the consensus of $33.2 billion (+38% Y/Y), 12.2%, and $3.68. He modeled fiscal 2027 sales of $39.0 billion (+18% Y/Y), adjusted gross margins of 14.3%, and adjusted EPS of $5.02. This is versus the consensus of $39.3 billion (+18% Y/Y), 15.5%, and $4.52.
With server sales typically a 15%-30% gross margin business, Cassidy noted that Supermicro could improve its gross margins as it ships solutions to more Enterprise customers.
Price Action: SMCI stock is down 1.39% at $37.71 at last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44218665/servicenow-eyes-3-billion-ai-deal-targets-boost-from-moveworks-chatbot-tech" target="_blank" rel="noreferrer noopener">ServiceNow Eyes $3 Billion AI Deal, Targets Boost From Moveworks Chatbot Tech</a></li>
</ul>
Photo: Shutterstock

SMCI

Supermicro's AI Boom, Liquid Cooling Edge Spark Analyst Confidence In Growth Potential

RBC Capital analyst Paul Treiber maintains Constellation Software (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CSU#TSX">CSU</a>) with a Outperform and raises the price target from C$5300 to C$5700.

TSX:CSU

RBC Capital Maintains Outperform on Constellation Software, Raises Price Target to C$5700

B of A Securities analyst Geoff Meacham maintains Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) with a Buy and lowers the price target from $51 to $48.

B of A Securities Maintains Buy on Avidity Biosciences, Lowers Price Target to $48

On Saturday, Bristol Myers Squibb&nbsp;&amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) revealed data from the pivotal Phase 3 POETYK PsA-2 trial (IM011-055) evaluating the efficacy and safety of&nbsp;Sotyktu&nbsp;(deucravacitinib) in adults with active <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">psoriatic arthritis (PsA)</a>.
The POETYK PsA-2 trial met its primary endpoint, with a significantly greater proportion of&nbsp;Sotyktu-treated patients&nbsp;achieving&nbsp;ACR20 response (at least a 20% improvement in signs and symptoms of disease) compared with placebo at Week 16 (54.2% versus 39.4%, respectively; p=0.0002).
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44190384/bristol-myers-opdivo-plus-yervoy-combo-therapy-secures-european-approval-for-untreated-liver-cancer-patients" rel="noreferrer noopener">Bristol Myers&#8217; Opdivo Plus Yervoy Combo Therapy Secures European Approval For Untreated Liver Cancer Patients</a>
The overall safety profile of&nbsp;Sotyktu&nbsp;through 16 weeks of treatment was consistent with that established in a Phase 2 PsA clinical trial and Phase 3 moderate-to-severe plaque <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44209193/bristol-myers-squibb-presents-late-breaking-data-from-phase-3-poetyk-psa-2-trial-demonstrating-sup" rel="noreferrer noopener">psoriasis clinical trials</a>.
The new data, representing the first disclosure of data for the Phase 3 POETYK trials in PsA, were presented at the American Academy of Dermatology.
Additionally, treatment with&nbsp;Sotyktu&nbsp;met important secondary endpoints across PsA disease activity at Week 16, demonstrating improvement across clinical signs and symptoms, extra-articular manifestations, and patient-reported outcomes.
More&nbsp;Sotyktu-treated patients achieved a Psoriasis Area and Severity Index (PASI) 75 response compared with placebo.
In the POETYK PsA-2 trial, no new safety signals were identified.
Bristol Myers Squibb will work with key investigators to present additional Phase 3 POETYK PsA program data at upcoming medical congresses this year.
Sotyktu&nbsp;is approved for the treatment of adults with moderate-to-severe plaque psoriasis.
Price Action: BMY stock is up 2.82% at $62.82 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44224370/grab-teams-up-with-global-self-driving-giants-eyes-future-of-ride-hailing-in-southeast-asia" target="_blank" rel="noreferrer noopener">Grab Teams Up With Global Self-Driving Firms, Eyes Future of Ride-Hailing In Southeast Asia</a></li>
</ul>
Photo via Shutterstock

Biotech

Large Cap

Health Care

Bristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis

B of A Securities analyst Tazeen Ahmad maintains Merus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) with a Buy and lowers the price target from $73 to $70.

MRUS

B of A Securities Maintains Buy on Merus, Lowers Price Target to $70

RBC Capital analyst Jimmy Shan maintains Automotive Props REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/APR#TSX">APR</a>) with a Sector Perform and lowers the price target from C$13 to C$12.

TSX:APR

TSX:APR/UN

RBC Capital Maintains Sector Perform on Automotive Props REIT, Lowers Price Target to C$12

B of A Securities analyst Tazeen Ahmad maintains 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Buy and lowers the price target from $42 to $40.

FDMT

B of A Securities Maintains Buy on 4D Molecular Therapeutics, Lowers Price Target to $40

WIIM

ALUR

BEDU

BROS

BYON

CLEU

DKNG

DUOL

FNKO

FRSX

GENI

MULN

PENN

PLBY

PTON

SERV

SOND

Sony Group Corporation American Depositary Shares

SONY

TRNR

XPOF

ZSPC

Shares of companies within the broader consumer discretionary sector are trading lower amid recession worries due to tariffs and trade policy uncertainty. Additionally, consumer spending is expected to be impacted, which is weighing on the industry.

RBC Capital analyst Sabahat Khan maintains Aecon Group (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ARE#TSX">ARE</a>) with a Sector Perform and lowers the price target from C$27 to C$20.

TSX:ARE

RBC Capital Maintains Sector Perform on Aecon Group, Lowers Price Target to C$20

B of A Securities analyst Tazeen Ahmad maintains Denali Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) with a Buy and lowers the price target from $30 to $28.

DNLI

B of A Securities Maintains Buy on Denali Therapeutics, Lowers Price Target to $28

On Saturday, Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) and Kyowa Kirin Co., Ltd. <a href="https://www.benzinga.com/general/biotech">announced new results</a> from the ongoing ROCKET Phase 3 trial program rocatinlimab in moderate to severe atopic dermatitis (AD).
The IGNITE study evaluated two dose strengths of rocatinlimab and met its co-primary endpoints and all key secondary<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44208802/amgen-and-kyowa-kirin-provide-top-line-results-from-rocatinlimab-phase-3-ignite-study-in-adults-wi" rel="noreferrer noopener"> endpoints versus placebo</a>.
<ul>
<li>At week 24, 42.3% of patients in the higher dose group achieved ≥75% reduction from baseline in Eczema Area and Severity Index score (EASI-75), a 29.5% difference vs. placebo, and 36.3% vs. 23.4% in the lower dose group.</li>
<li>In the higher dose group, 23.6% of patients achieved a validated Investigator&#8217;s Global Assessment for Atopic Dermatitis score of 0 (clear) or 1 (almost clear) with a ≥2-point reduction from baseline (vIGA-AD 0/1) at week 24, representing a 14.9% difference vs. placebo.</li>
<li>In the lower dose group, 19.1% of patients achieved this endpoint, a 10.3% difference vs. placebo.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44159237/amgen-challenges-novo-nordisk-and-eli-lilly-as-its-monthly-weight-loss-drug-maritide-enters-two-late-stage-trials" rel="noreferrer noopener">Amgen Challenges Novo Nordisk&#8217;s Ozempic And Eli Lilly&#8217;s Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials</a>
In addition, IGNITE met the endpoint of the revised Investigator&#8217;s Global (rIGA) Assessment score of 0/1 with a ≥2-point reduction from baseline.
<ul>
<li>At week 24, 22.7% of patients in the higher dose group achieved this endpoint, a 14.4% difference vs. placebo.</li>
<li>In the lower dose group, 16.3% of patients achieved this endpoint, an 8.0% difference vs. placebo.</li>
</ul>
The ROCKET program is also informed by the results of the SHUTTLE and VOYAGER studies.
<ul>
<li>The SHUTTLE study evaluated two dose strengths of rocatinlimab in combination with topical corticosteroids (TCS) and/or topical calcineurin inhibitors (TCI) in 746 adults using the same co-primary endpoints as IGNITE. The study met its co-primary and all key secondary endpoints.
<ul>
<li>For EASI-75, 52.3% of patients in SHUTTLE&#8217;s higher dose group achieved the endpoint, a 28.7% difference vs. placebo, while 54.1% of patients in the lower dose group achieved the endpoint, a 30.4% difference vs. placebo.</li>
<li>For vIGA-AD 0/1, 26.1% of SHUTTLE patients in the higher dose group achieved the endpoint, a 13.8% difference vs. placebo. In the lower dose group: 25.8% vs. 13.5%.</li>
<li>For rIGA 0/1, 23.3% of SHUTTLE patients in the higher dose group achieved the endpoint, an 11.5% difference vs. placebo and 22.7% vs. 10.9% in the lower dose group.</li>
</ul>
</li>
</ul>
The VOYAGER study demonstrated that rocatinlimab does not interfere with responses to tetanus and meningococcal vaccinations.
William Blair writes rocatinlimab results validate the OX40 mechanism, likely supporting a moderate commercial opportunity for patients after Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) and Regeneron Pharmaceutical Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) Dupixent and Eli Lilly &amp; Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Ebglyss.
Price Action: AMGN stock is up 2.4% at $332.90 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44223752/india-based-sun-pharma-to-buy-us-cancer-firm-checkpoint-therapeutics-for-410-per-share" target="_blank" rel="noreferrer noopener">India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details</a></li>
</ul>
Photo: Shutterstock

AMGN

REGN

Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study

Press Releases

Fortive Declares Regular Quarterly Dividend on its Common Stock

Fortive Announces Board Chair Transition

Fortive Announces Board Designees for the New Precision Technologies Company, to be Named Ralliant Corporation

Fortive Reports Strong Fourth Quarter and Full Year 2024 Results; Introduces First Quarter and Full Year 2025 Outlook

Fortive to Present at Citi Global Industrial Tech & Mobility Conference

Fortive to Present at Barclays Industrial Select Conference

Fluke EV Survey Highlights OEM and Technician Confidence Despite 68% Citing a Gap in Industry Adoption

Fortive Announces Appointment of Gregory Moore to Its Board of Directors

Fortive Appoints Mark Okerstrom Chief Financial Officer

Fortive to Present at J.P. Morgan 2025 Industrials Conference

EXPE

TRVG

Crane

Donaldson

Dover

ESAB

Flowserve

Graco

Chart Industries

IDEX

Ingersoll Rand

Illinois Tool Works

JBT Marel

Lincoln Electric Holdings, Inc. - Common Shares

Lincoln Electric Holdings

Middleby

Mueller Industries

Nordson

Otis Worldwide

Parker Hannifin

Pentair

RBC Bearings

Snap-on

SPX Technologies

Stanley Black & Decker, Inc. Common Stock

Stanley Black & Decker

Watts Water Technologies, Inc. Class A Common Stock

Watts Water Technologies

Xylem

RBC Capital

Wells Fargo

JP Morgan

Barclays

Truist Securities

포티브 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>)은 <a href="https://www.benzinga.com/quote/ftv/earnings" target="_blank" rel="noopener">2025년 2월 7일 금요일</a> 개장 전에 4분기 재무 실적을 발표할 예정이다.
애널리스트들은 워싱턴주 에버렛에 본사를 둔 포티브의 주당순이익은 전년 동기의 98센트보다 높은 1.12달러로 예상한다. 또한 분기 매출은 16억 3,000만 달러로 전년 동기 15억 8,000만 달러에 비해 증가할 것으로 예상하고 있다.
1월 29일, 포티브는 이사회가 샤미스타 "샤르" 두베이(Sharmistha &#8220;Shar&#8221; Dubey)를 의장으로 임명했다고 발표했다.
포티브 주가는 목요일 0.4% 상승하여 79.84달러로 마감했다.
벤징가 독자는 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie" target="_blank" rel="noopener">애널리스트 주식 등급</a> 페이지에서 최신 애널리스트 평가에 액세스할 수 있다. 최근 벤징가에서 가장 정확한 <a href="https://www.benzinga.com/quote/FTV/analyst-ratings" target="_blank" rel="noopener">애널리스트들이 포티브에 대해 어떻게 평가했는지 자세히 살펴보자.</a>
<ul>
<li>JP모건 애널리스트 스티븐 투사: 2025년 1월 15일, 비중확대 등급 유지, 목표주가 92달러에서 90달러 하향 조정, 정확도 68%</li>
<li>바클레이즈 애널리스트 줄리안 미첼: 2025년 1월 8일, 비중확대 등급 유지, 목표주가 95달러에서 90달러로 하향 조정, 정확도 75%</li>
<li>웰스파고 애널리스트 조셉 오데아: 2025년 1월 7일, 동일비중 등급 유지, 목표주가 77달러에서 80달러로 상향 조정, 정확도 63%</li>
<li>트루이스트 증권 애널리스트 제이미 쿡: 2024년 12월 19일, 매수 등급 유지, 목표주가 89달러에서 90달러로 상향 조정, 정확도 70%</li>
<li>씨티그룹 애널리스트 앤드류 카플로위츠: 2024년 12월 9일, 매수에서 중립 등급으로 하향, 목표주가 92달러에서 86달러로 하향 조정, 정확도 84%</li>
</ul>
<img loading="lazy" decoding="async" class="alignnone size-medium" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07022804/image-2-15-1024x583.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=2048" width="1024" height="583" />
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Fortive

뉴스

에 대한 최신 뉴스 Fortive (NYSE:FTV) 주식

금요일, 2월 07, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌